These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1886533)
1. [The effects of treatment with growth hormone alone or in combination with oxandrolone in a group of Turner's syndrome children. A preliminary study]. Cherubini V; Cardinale G; Panfoli C; Pecora R; Lorenzetti L; Bartolotta E Minerva Pediatr; 1991 Jun; 43(6):465-9. PubMed ID: 1886533 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group. Rosenfeld RG Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013 [TBL] [Abstract][Full Text] [Related]
3. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone therapy in Turner's syndrome. O'Shea D; Powell D Ir Med J; 1992 Jun; 85(2):68-9. PubMed ID: 1628947 [TBL] [Abstract][Full Text] [Related]
13. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264 [TBL] [Abstract][Full Text] [Related]
14. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. Cacciari E; Mazzanti L J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710 [TBL] [Abstract][Full Text] [Related]
15. Optimization of treatment in Turner's syndrome. Gracia Bouthelier R; Oliver Iguacel A; Gonzalez Casado I; Alcalde de Alvaré A J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():427-34. PubMed ID: 15134303 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences]. Naeraa RW; Nielsen J; Kastrup KW Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017 [TBL] [Abstract][Full Text] [Related]
17. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome. Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126 [TBL] [Abstract][Full Text] [Related]
18. [The current treatment concept of Turner syndrome]. Blümel P; Stögmann W Padiatr Padol; 1989; 24(1):81-9. PubMed ID: 2654820 [TBL] [Abstract][Full Text] [Related]
19. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial. Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249 [TBL] [Abstract][Full Text] [Related]
20. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]